Financhill
Back

Apellis Pharmaceuticals Vs. Akero Therapeutics Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.64
Seasonality Move:
-9.52%
Sell
50

AKRO
Akero Therapeutics

Last Price:
$54.08
Seasonality Move:
30.3%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.69. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $54.20. The Score for AKRO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $54.20
    The current trend is moderately bullish and AKRO is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.98 Sell
Chaikin Money Flow: -561522 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.2 - 19.06) Sell
Bollinger Bands (100): (17.72 - 26.54) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.93 Buy
Relative Strength Index (14 RSI): 62.96 Buy
Chaikin Money Flow: -901741 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.9 - 55.3) Buy
Bollinger Bands (100): (39.56 - 52.16) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.56 Sell
20-day SMA: 18.3 Sell
50-day SMA: 18.27 Sell
200-day SMA: 26.83 Sell
8-day EMA: 18.25 Sell
20-day EMA: 18.36 Sell
50-day EMA: 19.23 Sell
200-day EMA: 26.97 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.61 Sell
20-day SMA: 51.97 Buy
50-day SMA: 45.22 Buy
200-day SMA: 37.36 Buy
8-day EMA: 54.38 Sell
20-day EMA: 51.87 Buy
50-day EMA: 47.62 Buy
200-day EMA: 39.21 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):